Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2011

Feb 28, 2011

30291_dirs_2011-02-28_7de5282e-9a40-4246-905e-9ecb9d1f4962.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2011-02-24

Reporting Person: SCHNEIER CRAIG ERIC (EVP, HR, Public Affairs & Comm)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-02-24 Common Stock F 1161 $67.26 Disposed 18707.2794 Direct
2011-02-24 Common Stock F 995 $67.26 Disposed 17712.2794 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 460 Indirect